In a review of NHANES data, researchers examined the lifetime risk for diabetes in the context of change in body mass index over 10 years. To see the results, read more.
In a recent study, researchers evaluated the performance of limited and expanded screening criteria recommended by the USPSTF for the detection of potential diabetes and prediabetes cases in adult...
Researchers performed a network meta-analysis of 236 trials and more than 176,000 participants to compare the effectiveness of SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors in reducing mortality...
In the Vitamin D for Established Type 2 Diabetes (DDM2) Study, researchers investigated the effects of vitamin D supplementation on insulin secretion rate and hemoglobin A1c in metformin-treated patients...
In a new study of 62,565 men with available weight and height data from childhood and early adulthood, researchers aimed to determine the effect of childhood overweight on the risk of adult-onset type 2...
The success of the DURATION-7 trial has led the US Food and Drug Administration to approve a new adjunctive therapy to basal insulin for adults with type 2 diabetes with inadequate glycemic control.
The CVD REAL study, an international study of more than 400,000 participants, determined hazard ratios for hospitalization for heart failure, death from heart failure, stroke, and myocardial infarction.
...
Recommendations for appropriate hemoglobin A1c targets for type 2 diabetes have changed, according to the Clinical Guidelines Committee of the American College of Physicians.
